Medlive Technology Co., Ltd. (HKG:2192)
7.51
-0.10 (-1.31%)
May 27, 2026, 4:09 PM HKT
Medlive Technology Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Medlive Technology stock has a target of $17.00, which predicts a 126.36% increase from the current stock price of 7.51.
Price Target: $17.00 (+126.36%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 13, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Medlive Technology is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 4 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $17.00 | Buy | Maintains | $17.00 | +126.36% | Apr 13, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $11.40 | Buy | Maintains | $11.40 | +51.80% | Apr 2, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $10.90 | Buy | Maintains | $10.90 | +45.14% | Mar 31, 2026 |
Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.